PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29704003-0	2018	Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis.	Odevixibat	32-37	solute carrier family 10 member 2	Homo sapiens	17-21	
32653991-9	2020	The clinical programs of 2 IBAT inhibitors in development for the treatment of pediatric cholestatic liver diseases, maralixibat and odevixibat, are highlighted.	Odevixibat	133-143	solute carrier family 10 member 2	Homo sapiens	27-31	
29704003-3	2018	Our aim was to assess tolerability and effect on pruritus of the selective IBAT inhibitor A4250 in patients with primary biliary cholangitis (PBC).	Odevixibat	90-95	solute carrier family 10 member 2	Homo sapiens	75-79